Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA.
J Biol Chem. 2012 Nov 30;287(49):41514-22. doi: 10.1074/jbc.M112.404871. Epub 2012 Oct 11.
Several reports have indicated that miR-140, a possible tumor suppressor microRNA (miR), is down-regulated in breast tumors compared with normal breast tissues. However, the role of miR-140 in breast tumorigenesis is unclear. We initiated studies that examined estrogen receptor α (ERα) signaling in the tissue-specific regulation of miR-140 in breast cancer. We found that estrogen stimulation of ERα-positive breast cancer cells resulted in decreased miR-140 expression. We performed promoter analyses and examined predicted ERα binding elements in the miR-140 promoter using luciferase constructs of a miR-140 promoter deletion series. Our studies revealed that ERα binds to one specific estrogen response element flanking the miR-140 promoter and consequently suppresses miR-140 transcription. We found that the stem cell self-renewal regulator SOX2 is a novel target of miR-140, and that this miR-140/SOX2 pathway critically regulates breast tumor-initiating cell survival, providing a new link between ERα signaling and breast cancer stem cell maintenance.
有几份报告指出,miR-140 是一种可能的肿瘤抑制 microRNA(miR),与正常乳腺组织相比,在乳腺癌中下调。然而,miR-140 在乳腺癌发生中的作用尚不清楚。我们开始研究 ERα 信号在 miR-140 在乳腺癌中的组织特异性调控中的作用。我们发现,雌激素刺激 ERα 阳性乳腺癌细胞导致 miR-140 表达降低。我们进行了启动子分析,并使用 miR-140 启动子缺失系列的荧光素酶构建体检查了 miR-140 启动子中预测的 ERα 结合元件。我们的研究表明,ERα 结合到 miR-140 启动子侧翼的一个特定的雌激素反应元件上,从而抑制 miR-140 的转录。我们发现,干细胞自我更新调节剂 SOX2 是 miR-140 的一个新靶标,而这个 miR-140/SOX2 途径对乳腺肿瘤起始细胞的存活至关重要,为 ERα 信号和乳腺癌干细胞维持之间提供了新的联系。